Navigation Links
Plato BioPharma, Inc Appoints New Board Member
Date:2/10/2011

WESTMINSTER, Colo., Feb. 10, 2011 /PRNewswire/ -- Plato BioPharma, Inc ("PBI") announced today that its Board of Directors has appointed a new director, Mr. Dan Mitchell, effective November 1, 2010.  Dan has been in the venture capital industry for over 25 years focused on early stage opportunities primarily in healthcare and biotech industries.  Dan also serves on the Boards of Directors of Kalypto Medican, GlobeImmune, and Apoplogic.

"Dan is an outstanding addition to the Plato BioPharma Board," said Craig F. Plato, CEO and founder of Plato BioPharma. "His substantial experience and financial background will serve both our shareholders and customers well as PBI continues to grow and expand its capabilities and offerings."

Dan began his venture career at the First National Bank of Chicago's Institutional Venture Capital Fund, and then co-founded Capital Health Venture Partners, a healthcare-focused venture fund in 1985.  In 1996 he co-founded Sequel Venture Partners ("Sequel"). Sequel invests in seed and early stage opportunities primarily in the Front Range of Colorado.  His prior investments include Pyxis (acq. by Cardinal Health), Genomic Solutions (acq. by Harvard Bioscience), Tetra Technologies, Quovadx, and Myogen (acq. by Gilead Sciences, Inc).

Founded in 2009, Plato BioPharma, Inc is a leading preclinical contract research organization (CRO).  The company offers expert drug discovery and development capabilities in cardiovascular, renal, pulmonary, and hepatic disease therapeutic areas.  PBI provides an integrated research platform from the in-life phase through clinical chemistry, biomarker, and histological analyses.  The company specializes in custom study design and execution engagements ranging from pharmacokinetics through disease model and proof-of-concept evaluation.  PBI is headquartered in Westminster, Colorado.

Bob Leahy 1-303-506-6960


'/>"/>
SOURCE Plato BioPharma, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
3. Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference.
4. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
5. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
6. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
7. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
8. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
9. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
10. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
11. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... MedMark Treatment Centers, a ... facility in the Cincinnati, OH suburb of Milford. MedMark Milford provides proven treatment ... clinic, located at 749C State Route 28 in Milford, is now accepting patients. ...
(Date:11/11/2019)... ... 11, 2019 , ... Oak Street Health , a network of primary ... centers in Greensboro and Charlotte, with an additional center in Charlotte under development. Committed ... model of care that emphasizes quality of care rather than quantity of services. Its ...
(Date:11/11/2019)... ... November 11, 2019 , ... MAPS and ... implementation of joint projects for the benefit of biomedical professionals in the ... professionals to leverage their roles in the research, development, and commercialization activities ...
Breaking Medicine Technology:
(Date:11/14/2019)... ... November 14, 2019 , ... BioInformatics Inc., part of Science and Medicine Group, ... that 7 companies have been nominated for a Life Science Industry Award ... the Life Science Industry Awards have recognized manufacturers of the “tools of science” that ...
(Date:11/12/2019)... ... ... AI for preventable harm analytics leader Jvion today announced that Jvion was included ... AI”, which provides a “tip of the spear” analysis of the healthcare AI market. ... complete a full KLAS analysis, Jvion was featured as having “by far the largest ...
(Date:11/12/2019)... , ... November 12, 2019 , ... ... and compliance management, today announced the release of new features for custom branding. ... platform interface and emails to match their physical brand attributes. Customizable attributes include ...
(Date:11/11/2019)... ... November 11, 2019 , ... Last year’s expo was a resounding success ... box buyers like Costco, Walmart, and GNC. Exhibitors included some of the biggest ... , This year, CBD.io and partners, are once again set to ...
(Date:11/9/2019)... ... November 08, 2019 , ... The Women’s Dermatologic Society (WDS) ... health concerns. The WDS Board of Directors appointed Molly Hinshaw, MD to fill the ... current March 2019-March 2020 term and will be presented to the membership as the ...
Breaking Medicine News(10 mins):